Medicare utilization — JORDAN LEIGH DABEL (NP)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 8,160 | 12 | $0 | $3,442 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,750 | 18 | $0 | $46,398 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 194 | 14 | $0 | $19 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 71 | 59 | $0 | $3,456 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 67 | 37 | $0 | $2,817 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·